Nektar Therapeutics short interest in 2026
In 2026, Nektar Therapeutics's disclosed short interest ran from 16.04% of shares outstanding on 15 Jan 2026 to 16.80% on 15 Sep 2026, a change of +0.76 percentage points. The year's high was 24.04% on 30 Jun 2026 and its low 12.66% on 15 Apr 2026, averaging 17.02% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.45 days on 31 Aug 2026. Full history: Nektar Therapeutics.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 16.04% (15 Jan 2026)
- End of year
- 16.80% (15 Sep 2026)
- Change
- +0.76 pp
- High
- 24.04% (30 Jun 2026)
- Low
- 12.66% (15 Apr 2026)
- Average
- 17.02%
- Highest days to cover
- 11.45 (31 Aug 2026)
- SEC filings marked
- 6
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 16.04% | 4.66 | |
| 30 Jan 2026 | 16.16% | 4.63 | |
| 13 Feb 2026 | 17.16% | 1.56 | |
| 27 Feb 2026 | 16.43% | 3.43 | |
| 13 Mar 2026 | 12.79% | 3.79 | results (8-K), 10-K filed |
| 31 Mar 2026 | 12.77% | 4.34 | |
| 15 Apr 2026 | 12.66% | 5.78 | |
| 30 Apr 2026 | 14.30% | 2.47 | |
| 15 May 2026 | 15.23% | 5.21 | results (8-K), 10-Q filed |
| 29 May 2026 | 16.08% | 5.31 | |
| 15 Jun 2026 | 17.23% | 4.93 | |
| 30 Jun 2026 | 24.04% | 4.47 | |
| 15 Jul 2026 | 23.77% | 6.97 | |
| 31 Jul 2026 | 21.97% | 8.62 | |
| 14 Aug 2026 | 18.07% | 10.43 | results (8-K), 10-Q filed |
| 31 Aug 2026 | 17.77% | 11.45 | |
| 15 Sep 2026 | 16.80% | 7.57 |
See also: Nektar Therapeutics's full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.